1. A method for introducing a polypeptide comprising an epidermal growth factor-like (EGF-like) domain to a mammal, said method comprising: administering a polypeptide comprising an epidermal growth factor-like (EGF-like) domain, followed neurological injury in said mammal inachalo administering at least two days after neurological povrezhdeniya.2. A method according to Claim. 1, wherein said initial stage of start of at least three days after neurological povrezhdeniya.3. A method according to Claim. 1, wherein said initial stage of start of at least seven days after neurological povrezhdeniya.4. A method according to Claim. 1, where the EGF-like domain encoded gene neuregulin (NRG) -1, gene (NRG) -2, gene (NRG) -3, gene (NRG) -4.5. A method according to Claim. 1, wherein said polypeptide is a GGF2.6. A method according to Claim. 1, wherein said mammal is a cheloveka.7. The method of administration of a polypeptide comprising such epidermal growth factor (EGF-like) domain to a mammal, said method comprising: administering a polypeptide comprising such an Epidermal Growth Factor (EGF-like) domain, followed nevrologicheskogopovrezhdeniya in said mammal top administration within six hours after neurological damage iprodolzhenie steps of introducing a time period of more than six hours after povrezhdeniya.8. A method according to claim. 7, where the continuous phase comprises the steps of administering continued for a period of more than 48 hours after povrezhdeniya.9. A method according to claim. 7, where the continuous phase comprises the steps of administering continued for a period of more than 72 hours after povrezhdeniya.10. Cn1. Способ введения полипептида, содержащего подобный эпидермальному фактору роста (EGF-подобный) домен, млекопитающему, где указанный способ включает:введение полипептида, содержащего подобный эпидермальному фактору роста (EGF-подобный) домен, после неврологического повреждения у указанного млекопитающего иначало введения по меньшей мере че
